E0 ConsensusPreliminaryPEM not requiredReview-NarrativePeer-reviewedReviewed
Clinical correlates of infection with human herpesvirus-6.
Krueger, G R, Klueppelberg, U, Hoffmann, A et al. · In vivo (Athens, Greece) · 1994
Quick Summary
This review examines connections between human herpesvirus-6 (HHV-6), a common virus most people catch as infants, and various illnesses including ME/CFS. The virus usually stays dormant in the body after infection, but in some people it may reactivate and be linked to several health conditions. The authors reviewed existing knowledge about which diseases show signs of active HHV-6 infection.
Why It Matters
This early literature review established HHV-6 as a potential pathogenic factor in ME/CFS, helping motivate subsequent viral investigations in the condition. It provided an important foundation for researchers exploring whether viral reactivation contributes to post-infectious illnesses and immune dysregulation in ME/CFS populations.
Observed Findings
- HHV-6 replicating virus can be isolated from patients with chronic fatigue syndrome alongside elevated antibody titers
- HHV-6 reactivation is associated with infectious mononucleosis-like illness in older individuals
- HHV-6 antibody elevation correlates with various lymphoid, hematopoietic, and autoimmune disorders
- HHV-6 primary infection typically establishes lifelong latency after initial childhood exposure
Inferred Conclusions
- HHV-6 reactivation may be implicated in the pathogenesis of multiple conditions including chronic fatigue syndrome
- The wide spectrum of diseases associated with elevated HHV-6 titers suggests the virus plays a broader role in immune-mediated pathology
- HHV-6 may act as a trigger or cofactor in various lymphoproliferative and autoimmune conditions rather than causing isolated disease
Remaining Questions
- What proportion of ME/CFS patients have evidence of active HHV-6 replication versus latency, and how does this compare to healthy controls?
- What mechanisms explain why some HHV-6-infected individuals develop disease while others remain asymptomatic?
- Does HHV-6 reactivation cause immune dysfunction in ME/CFS, or does underlying immune dysfunction allow viral reactivation?
What This Study Does Not Prove
This review does not establish that HHV-6 causes ME/CFS or determine the prevalence of active HHV-6 infection in ME/CFS patients compared to controls. It identifies associations and presence of viral antibodies but cannot distinguish between causation, reactivation secondary to immune dysfunction, or incidental co-infection. The methodology does not allow causal claims about HHV-6's role in disease pathogenesis.
Tags
Symptom:Fatigue
Biomarker:AutoantibodiesBlood Biomarker
Phenotype:Infection-Triggered
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- PMID
- 7893974
- Review status
- Editor reviewed
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.